![]() |
Name |
Trichodermatide A
|
Molecular Formula | C22H32O7 | |
IUPAC Name* |
(1R,3S,4S,6R,9S,10S,15R,18S)-4-hexyl-9,10,15-trihydroxy-5,11,19-trioxapentacyclo[8.7.1.13,6.06,18.012,17]nonadec-12(17)-en-16-one
|
|
SMILES |
CCCCCC[C@H]1[C@@H]2C[C@@H]3[C@@H]4[C@@](O2)(O1)CC[C@@H]([C@]4(OC5=C3C(=O)[C@@H](CC5)O)O)O
|
|
InChI |
InChI=1S/C22H32O7/c1-2-3-4-5-6-14-16-11-12-18-15(8-7-13(23)19(18)25)29-22(26)17(24)9-10-21(27-14,28-16)20(12)22/h12-14,16-17,20,23-24,26H,2-11H2,1H3/t12-,13+,14-,16-,17-,20+,21+,22+/m0/s1
|
|
InChIKey |
KBMYUOJGZWMLOK-OBPUOHQXSA-N
|
|
Synonyms |
Trichodermatide A; DTXSID201043782; (1R,3S,4S,6R,9S,10S,15R,18S)-4-Hexyl-9,10,15-trihydroxy-5,11,19-trioxapentacyclo[8.7.1.13,6.06,18.012,17]nonadec-12(17)-en-16-one; 1004302-91-3
|
|
CAS | 1004302-91-3 | |
PubChem CID | 24777079 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 408.5 | ALogp: | 1.9 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 105.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 29 | QED Weighted: | 0.601 |
Caco-2 Permeability: | -4.783 | MDCK Permeability: | 0.00002970 |
Pgp-inhibitor: | 0.977 | Pgp-substrate: | 0.117 |
Human Intestinal Absorption (HIA): | 0.131 | 20% Bioavailability (F20%): | 0.453 |
30% Bioavailability (F30%): | 0.677 |
Blood-Brain-Barrier Penetration (BBB): | 0.239 | Plasma Protein Binding (PPB): | 87.28% |
Volume Distribution (VD): | 1.377 | Fu: | 5.14% |
CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.926 |
CYP2C19-inhibitor: | 0.061 | CYP2C19-substrate: | 0.574 |
CYP2C9-inhibitor: | 0.047 | CYP2C9-substrate: | 0.059 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.247 |
CYP3A4-inhibitor: | 0.146 | CYP3A4-substrate: | 0.183 |
Clearance (CL): | 14.008 | Half-life (T1/2): | 0.104 |
hERG Blockers: | 0.077 | Human Hepatotoxicity (H-HT): | 0.245 |
Drug-inuced Liver Injury (DILI): | 0.136 | AMES Toxicity: | 0.423 |
Rat Oral Acute Toxicity: | 0.896 | Maximum Recommended Daily Dose: | 0.893 |
Skin Sensitization: | 0.814 | Carcinogencity: | 0.535 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.018 |
Respiratory Toxicity: | 0.87 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003134 | ![]() |
0.429 | D04VIS | ![]() |
0.271 | ||
ENC005832 | ![]() |
0.418 | D00CTS | ![]() |
0.268 | ||
ENC005892 | ![]() |
0.388 | D0S0NK | ![]() |
0.248 | ||
ENC005467 | ![]() |
0.388 | D0L7AS | ![]() |
0.248 | ||
ENC005831 | ![]() |
0.366 | D0XN8C | ![]() |
0.237 | ||
ENC002090 | ![]() |
0.359 | D04QNO | ![]() |
0.235 | ||
ENC005893 | ![]() |
0.339 | D0Y7IU | ![]() |
0.235 | ||
ENC002643 | ![]() |
0.327 | D02AXG | ![]() |
0.231 | ||
ENC005927 | ![]() |
0.327 | D0Z1FX | ![]() |
0.226 | ||
ENC002146 | ![]() |
0.327 | D0V0IX | ![]() |
0.226 |